212 related articles for article (PubMed ID: 34338136)
21. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
Tang J; Ma W; Luo L
Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
23. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
24. A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
Lan T; Lu Y; Xiao Z; Xu H; He J; Hu Z; Mao W
PeerJ; 2019; 7():e7353. PubMed ID: 31380150
[TBL] [Abstract][Full Text] [Related]
25. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L
Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101
[TBL] [Abstract][Full Text] [Related]
27. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
[TBL] [Abstract][Full Text] [Related]
28. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma.
Chen X; Zhang W; Zhu H; Lin F
Med Sci Monit; 2021 Feb; 27():e928949. PubMed ID: 33577492
[TBL] [Abstract][Full Text] [Related]
30. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
31. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
32. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
33. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
34. A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival.
Tian B; Hou M; Zhou K; Qiu X; Du Y; Gu Y; Yin X; Wang J
Front Cell Dev Biol; 2021; 9():717462. PubMed ID: 34589485
[TBL] [Abstract][Full Text] [Related]
35. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
36. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
37. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
Liu G; Wang H; Fu JD; Liu JY; Yan AG; Guan YY
APMIS; 2017 Jul; 125(7):614-622. PubMed ID: 28430373
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
Wang X; Dai C; Ye M; Wang J; Lin W; Li R
Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
[TBL] [Abstract][Full Text] [Related]
39. Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma.
Chen R; Sun K; Hou Y; Shen J; Chen J; Dong F; Wang X; Yang L; Zhang L
Biomed Res Int; 2022; 2022():8776678. PubMed ID: 36467881
[TBL] [Abstract][Full Text] [Related]
40. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]